Applied Genetic Technologies Corp.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
GILDGilead Sciences, Inc. 3.67%75.531.0%$2162.57m
AMGNAmgen, Inc. 4.82%207.821.3%$956.71m
REGNRegeneron Pharmaceuticals, Inc. 5.48%474.142.6%$818.02m
BIIBBiogen, Inc. 5.81%314.001.5%$753.24m
MRNAModerna, Inc. 0.83%30.300.0%$645.53m
VRTXVertex Pharmaceuticals, Inc. 6.08%230.451.9%$558.93m
ILMNIllumina, Inc. 1.20%272.293.5%$488.49m
ALXNAlexion Pharmaceuticals, Inc. 3.85%87.242.0%$275.98m
AAgilent Technologies, Inc. 3.11%72.931.6%$243.86m
EXASEXACT Sciences Corp. 0.88%58.4121.0%$207.27m
INCYIncyte Corp. 3.70%71.512.5%$173.74m
SGENSeattle Genetics, Inc. 4.51%114.206.1%$169.61m
BMRNBioMarin Pharmaceutical, Inc. 3.14%82.014.3%$165.40m
NVAXNovavax, Inc. 9.16%14.25114.7%$163.74m
CODXCo-Diagnostics, Inc. -9.95%8.240.0%$133.73m

Company Profile

Applied Genetic Technologies Corp. engages in the development of gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. It has clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL.